Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001019687-14-000490
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-12 19:25:31
Reporting Period:
2014-02-11
Filing Date:
2014-02-12
Accepted Time:
2014-02-12 19:25:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1485003 Eleven Biotherapeutics Inc. EBIO Pharmaceutical Preparations (2834) 252025616
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590442 Partnership Limited Investment V3 Super Jafco Otemachi First Square, West Tower
11F, 1-5-1, Otenachi Chiyoda-Ku
Tokyo, Japan M0 100-0004
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-11 219,790 $10.00 219,790 No 4 P Direct
Common Stock Acquisiton 2014-02-11 1,574,803 $0.00 1,794,593 No 4 C Direct
Common Stock Acquisiton 2014-02-11 232,105 $0.00 2,026,698 No 4 C Direct
Common Stock Acquisiton 2014-02-11 60,853 $0.00 2,087,551 No 4 M Direct
Common Stock Acquisiton 2014-02-11 39,740 $0.00 2,127,291 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 C Direct
No 4 C Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2014-02-11 1,574,803 $0.00 1,574,803 $0.00
Common Stock Series B Preferred Stock Disposition 2014-02-11 232,105 $0.00 232,105 $0.00
Common Stock Common Stock Warrant (right to purchase) Disposition 2014-02-11 61,242 $0.00 60,853 $0.00
Common Stock Common Stock Warrant (right to purchase) Disposition 2014-02-11 39,994 $0.00 39,740 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Direct
0 No 4 C Direct
0 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. The aggregate number of shares of Issuer's Preferred Stock held by the Reporting Person converted into Common Stock immediately prior to the closing of the Issuer's initial public offering and has no expiration date. These shares converted into Common Stock on a 1-for-1 basis.
  2. The Reporting Person exercised warrants to purchase shares of Common Stock by cashless exercise immediately prior to the closing of the Issuer's initial public offering.